Drug
Travoprost (isomer Free)
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Treatment Failure | 893 | 72.9 | 101.3 | signal |
| 2 | Intraocular Pressure Increased | 84 | 43.7 | 44.8 | signal |
| 3 | Full Blood Count Abnormal | 42 | 26.5 | 26.9 | signal |
| 4 | Product Packaging Quantity Issue | 29 | 17.7 | 17.8 | signal |
| 5 | Eye Irritation | 122 | 14.5 | 15.1 | signal |
| 6 | Glaucoma | 41 | 14.1 | 14.3 | signal |
| 7 | Ocular Discomfort | 23 | 14.1 | 14.2 | signal |
| 8 | Ocular Hyperaemia | 83 | 11.8 | 12.1 | signal |
| 9 | Eye Pain | 90 | 10.8 | 11.1 | signal |
| 10 | Intervertebral Disc Degeneration | 15 | 10.7 | 10.7 | signal |
| 11 | Eye Discharge | 16 | 10.4 | 10.4 | signal |
| 12 | Eye Pruritus | 51 | 10.3 | 10.4 | signal |
| 13 | Retinal Detachment | 12 | 8.7 | 8.7 | signal |
| 14 | Oesophagitis | 13 | 7.9 | 7.9 | signal |
| 15 | Eye Inflammation | 11 | 7.7 | 7.8 | signal |
| 16 | Neoplasm | 13 | 7.5 | 7.5 | signal |
| 17 | Musculoskeletal Chest Pain | 15 | 6.4 | 6.5 | signal |
| 18 | Rhinorrhoea | 60 | 6.2 | 6.3 | signal |
| 19 | Vitreous Floaters | 9 | 6.1 | 6.1 | signal |
| 20 | Product Packaging Issue | 8 | 5.7 | 5.7 | signal |
| 21 | Wheezing | 51 | 5.7 | 5.8 | signal |
| 22 | Breast Cancer Metastatic | 9 | 5.6 | 5.6 | signal |
| 23 | Nasal Congestion | 48 | 5.4 | 5.5 | signal |
| 24 | Iron Deficiency Anaemia | 7 | 5.1 | 5.1 | signal |
| 25 | Eye Disorder | 24 | 4.9 | 4.9 | signal |
| 26 | Blood Pressure Systolic Increased | 14 | 4.7 | 4.8 | signal |
| 27 | Ileus | 8 | 4.3 | 4.3 | signal |
| 28 | Photophobia | 12 | 4.3 | 4.3 | signal |
| 29 | Hyponatraemia | 36 | 4.2 | 4.3 | signal |
| 30 | Basal Cell Carcinoma | 10 | 4.2 | 4.3 | signal |
| 31 | Lacrimation Increased | 19 | 4.2 | 4.2 | signal |
| 32 | Pain In Jaw | 17 | 4.0 | 4.0 | signal |
| 33 | Dry Eye | 29 | 4.0 | 4.0 | signal |
| 34 | Heart Rate Decreased | 21 | 3.9 | 4.0 | signal |
| 35 | Hypoglycaemia | 28 | 3.8 | 3.9 | signal |
| 36 | Transfusion | 6 | 3.8 | 3.8 | signal |
| 37 | Frequent Bowel Movements | 15 | 3.7 | 3.7 | signal |
| 38 | Conjunctivitis | 10 | 3.6 | 3.6 | signal |
| 39 | Product Substitution Issue | 31 | 3.6 | 3.6 | signal |
| 40 | Eye Infection | 6 | 3.5 | 3.6 | signal |
| 41 | Eye Swelling | 19 | 3.4 | 3.4 | signal |
| 42 | Visual Acuity Reduced | 17 | 3.4 | 3.4 | signal |
| 43 | Macular Degeneration | 6 | 3.3 | 3.3 | signal |
| 44 | Extra Dose Administered | 20 | 3.3 | 3.3 | signal |
| 45 | Coronary Artery Disease | 15 | 3.3 | 3.3 | signal |
| 46 | Eyelid Ptosis | 5 | 3.3 | 3.3 | signal |
| 47 | Cataract | 29 | 3.2 | 3.3 | signal |
| 48 | Hyperkalaemia | 17 | 3.2 | 3.2 | signal |
| 49 | Hypersensitivity | 90 | 3.2 | 3.3 | signal |
| 50 | Bradycardia | 25 | 3.1 | 3.1 | signal |
| 51 | Vision Blurred | 64 | 3.1 | 3.2 | signal |
| 52 | Foot Deformity | 5 | 3.0 | 3.0 | signal |
| 53 | Asthma | 50 | 3.0 | 3.0 | signal |
| 54 | Eyelid Oedema | 5 | 2.8 | 2.8 | signal |
| 55 | Madarosis | 5 | 2.8 | 2.8 | signal |
| 56 | Epistaxis | 32 | 2.8 | 2.9 | signal |
| 57 | Blindness Unilateral | 6 | 2.8 | 2.8 | signal |
| 58 | International Normalised Ratio Increased | 11 | 2.5 | 2.5 | signal |
| 59 | Blindness | 15 | 2.4 | 2.5 | signal |
| 60 | Mania | 6 | 2.4 | 2.4 | no signal |
| 61 | Rhabdomyolysis | 15 | 2.4 | 2.4 | signal |
| 62 | Product Dose Omission Issue | 101 | 2.4 | 2.4 | signal |
| 63 | Psoriatic Arthropathy | 13 | 2.1 | 2.1 | signal |
| 64 | Delusion | 5 | 2.1 | 2.1 | no signal |
| 65 | Cytokine Release Syndrome | 6 | 2.1 | 2.1 | no signal |
| 66 | Parkinsonism | 3 | 2.0 | 2.0 | no signal |
| 67 | Product Taste Abnormal | 4 | 2.0 | 2.0 | no signal |
| 68 | Product Availability Issue | 6 | 1.8 | 1.8 | no signal |
| 69 | Libido Decreased | 3 | 1.6 | 1.6 | no signal |
| 70 | Injection Site Swelling | 18 | 1.6 | 1.6 | no signal |
| 71 | Expired Product Administered | 7 | 1.4 | 1.4 | no signal |
| 72 | Diabetic Ketoacidosis | 5 | 1.4 | 1.4 | no signal |
| 73 | Circumstance Or Information Capable Of Leading To Medication Error | 6 | 1.2 | 1.2 | no signal |
| 74 | Exposure Via Skin Contact | 4 | 1.2 | 1.2 | no signal |
| 75 | Injection Site Bruising | 13 | 1.1 | 1.1 | no signal |
| 76 | Injection Site Haemorrhage | 11 | 0.9 | 0.9 | no signal |
| 77 | Wrong Technique In Device Usage Process | 6 | 0.9 | 0.9 | no signal |
| 78 | Device Difficult To Use | 6 | 0.6 | 0.6 | no signal |